Oncogenic mutations of PIK3CA in human cancers.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  2004-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/82_2010_68PMID 20535651PMCID PMC3164550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer.

  2009cited by this paper
• PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

  2009cited by this paper
• PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival

  2009cited by this paper
• Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma.

  2009cited by this paper
• Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women.

  2009cited by this paper
• PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients

  2009cited by this paper
• Molecular alterations of EGFR and PIK3CA in uterine serous carcinoma.

  2009cited by this paper
• FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo

  2009cited by this paper
• Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

  2008cited by this paper
• PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

  2008cited by this paper
• PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters

  2008cited by this paper
• AKT1E17K in human solid tumours

  2008cited by this paper
• Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses

  2008cited by this paper
• PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

  2008cited by this paper
• Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.

  2008cited by this paper
• Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

  2008cited by this paper
• PIK3CA mutation status in Japanese esophageal squamous cell carcinoma.

  2008cited by this paper
• PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

  2008cited by this paper
• PIK3CA cancer mutations display gender and tissue specificity patterns

  2008cited by this paper
• Rare PIK3CA hotspot mutations in carcinomas of the biliary tract

  2008cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

  2008cited by this paper
• Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences.

  2008cited by this paper
• PIK3CA, HRAS and KRAS gene mutations in human penile cancer.

  2008cited by this paper
• Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.

  2008cited by this paper
• Frequent mutations and amplifications of the PIK3CA gene in pituitary tumors.

  2008cited by this paper
• Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers

  2008cited by this paper
• PIK3CA mutations and copy number gains in human lung cancers.

  2008cited by this paper
• Multiplexed assays for detection of mutations in PIK3CA.

  2008cited by this paper
• An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer.

  2008cited by this paper
• PIK3CA mutation is predictive of poor survival in patients with colorectal cancer

  2007cited by this paper
• Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

  2007cited by this paper
• PIK3CA alterations in primary (de novo) and secondary glioblastomas

  2007cited by this paper
• Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene.

  2007cited by this paper
• Different Prognostic Roles of Mutations in the Helical and Kinase Domains of the PIK3CA Gene in Breast Carcinomas

  2007cited by this paper
• Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern

  2007cited by this paper
• PIK3CA gene amplification in Japanese non-small cell lung cancer.

  2007cited by this paper
• Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.

  2007cited by this paper
• [Screening for mutations in the hotspot mutation regions of PIK3CA gene in nasopharyngeal carcinoma].

  2007cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• Mutations of the PIK3CA gene in hereditary colorectal cancers

  2007cited by this paper
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

  2007cited by this paper
• Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma

  2007cited by this paper
• Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma

  2007cited by this paper
• PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma

  2007cited by this paper
• Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population

  2007cited by this paper
• PIK3CA mutation and amplification in human lung cancer

  2007cited by this paper
• Novel mutant‐enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• PIK3CA Mutations and PTEN Loss Correlate with Similar Prognostic Factors and Are Not Mutually Exclusive in Breast Cancer

  2007cited by this paper
• A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

  2007cited by this paper
• Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

  2007cited by this paper
• High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors.

  2007cited by this paper
• PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

  2006cited by this paper
• PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma

  2006cited by this paper
• Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA

  2006cited by this paper
• PIK3CA mutations are an early genetic alteration associated with FGFR3 mutations in superficial papillary bladder tumors.

  2006cited by this paper
• Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms

  2006cited by this paper
• PIK3CA mutations in oligodendroglial tumours

  2006cited by this paper
• Rare mutation of PIK3CA in meningiomas

  2006cited by this paper
• PIK3CA Gene Mutations in Pediatric and Adult Glioblastoma Multiforme

  2006cited by this paper
• PIK3CA mutations in breast cancer are associated with poor outcome

  2006cited by this paper
• Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus

  2006cited by this paper
• PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas

  2006cited by this paper
• Absence of hot spot mutations of the PIK3CA gene in acute myeloid leukaemia

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients

  2006cited by this paper
• Mutations of PIK3CA are rare in cutaneous melanoma

  2006cited by this paper
• PIK3CA mutations in nasopharyngeal carcinoma

  2006cited by this paper
• Automating sequence-based detection and genotyping of SNPs from diploid samples

  2006cited by this paper
• Mutations in PIK3CA are infrequent in neuroblastoma

  2006cited by this paper
• PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma

  2006cited by this paper
• Mutational analysis of beta-catenin and the RAS-RAF signalling pathway in early flat-type colorectal tumours.

  2006cited by this paper
• Cancer-specific mutations in PIK3CA are oncogenic in vivo

  2006cited by this paper
• PIK3CA and PTEN Mutations in Uterine Endometrioid Carcinoma and Complex Atypical Hyperplasia

  2006cited by this paper
• PIK3CA mutation status in Japanese lung cancer patients.

  2006cited by this paper
• PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

  2006cited by this paper
• High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.

  2005cited by this paper
• Mutations of PIK3CA in gastric adenocarcinoma

  2005cited by this paper
• PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

  2005cited by this paper
• Mutations of the PIK3CA gene are rare in human glioblastoma

  2005cited by this paper
• PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.

  2005cited by this paper
• The prevalence of PIK3CA mutations in gastric and colon cancer.

  2005cited by this paper
• PIK3CA mutations in advanced ovarian carcinomas

  2005cited by this paper
• Colorectal cancer: Mutations in a signalling pathway

  2005cited by this paper
• Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

  2005cited by this paper
• Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors.

  2005cited by this paper
• Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers

  2005cited by this paper
• Mutation of the PIK3CA gene in anaplastic thyroid cancer.

  2005cited by this paper
• Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.

  2005cited by this paper
• Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

  2005cited by this paper
• PIK3CA mutations in glioblastoma multiforme

  2005cited by this paper
• Melanoma genetics and the development of rational therapeutics.

  2005cited by this paper
• Genetic alteration and expression of the phosphoinositol‐3‐kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas

  2005cited by this paper
• Somatic mutation and gain of copy number of PIK3CA in human breast cancer

  2005cited by this paper
• Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression.

  2004cited by this paper
• Deregulated Akt3 Activity Promotes Development of Malignant Melanoma

  2004cited by this paper

• Cancer Stemness and Dedifferentiation in Anaplastic Thyroid Carcinoma: Insights into a Multigenic, Microenvironmental Network and the Role of CD44.

  2026cites this paper
• Gene Mutations and Related Molecular Events in Distant Metastasis of Cervical Cancer: A Review.

  2026cites this paper
• An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance

  2026cites this paper
• Mammalian Neuraminidase-1 is a Critical Target of Thromboxane Induced T-Cell Immunosuppression

  2026cites this paper
• Loss of PIK3CA allows in vitro growth but not in vivo progression of KRAS mutant lung adenocarcinoma in a syngeneic orthotopic implantation model

  2026cites this paper
• GenBlosum: On Determining Whether Cancer Mutations Are Functional or Random

  2026cites this paper
• Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies

  2025cites this paper
• Predictive biomarkers for targeted therapy in daily anatomic pathology for ovarian tumors

  2025cites this paper
• Correlation Between PIK3R1 Expression and Cell Growth in Human Breast Cancer Cell Line BT-474 and Clinical Outcomes

  2025cites this paper
• IBI-DT: a novel approach combining individualized Bayesian inference and decision tree for identifying cancer drivers and their interactions

  2025cites this paper
• Systematic Analysis of Network-driven Adaptive Resistance to CDK4/6 and Estrogen Receptor Inhibition using Meta-Dynamic Network Modelling

  2025cites this paper
• Transcriptomic Profile of Oral Cancer Lesions: A Proof-of-Concept Pilot Study of FFPE Tissue Sections

  2025cites this paper
• Comprehensive identification of a migrasomes-associated long non-coding RNA signature to predict the prognosis and treatment options in colon adenocarcinoma

  2025cites this paper
• Defining the Molecular Intricacies of Human Papillomavirus-Associated Tonsillar Carcinoma

  2025cites this paper
• Circulating tumor cells: indicators of cancer progression, plasticity and utility for therapies

  2025cites this paper
• Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation

  2025cites this paper
• Shared neoantigens for cancer immunotherapy

  2025cites this paper
• Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes.

  2025cites this paper
• Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor

  2025cites this paper
• Personalized Cancer Vaccines: Current Advances and Emerging Horizons

  2025cites this paper
• Combinatorial and fragment-based in silico design of PI3K-alpha natural hybrid antagonists for breast cancer therapeutics

  2025cites this paper
• Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: In silico and in vitro insights.

  2025cites this paper
• Discovery of a selective PI3Kα inhibitor via structure-based virtual screening for targeted colorectal cancer therapy

  2025cites this paper
• Effects of PIK3CA Gene Modifications on Radiosensitivity in Colorectal Cancer Cells

  2025cites this paper
• Detection of circulating tumor DNA (ctDNA) using a magnetic bead-assisted fluorescent and electrochemical biosensor system

  2025cites this paper
• The use of granulocyte colony-stimulating factors in the management of breast cancer patients

  2025cites this paper
• De-regulation of Aurora kinases by oncogenic HPV; implications in cancer development and treatment.

  2025cites this paper
• Role of the PI3K/AKT signaling pathway in the cellular response to Tumor Treating Fields (TTFields)

  2025cites this paper
• Case Report: Activated PI3-kinase-δ syndrome and ovarian malignancies: a case series from the European ESID-APDS registry

  2025cites this paper
• Inositol and PIP2/PIP3 Ratio: At the Crossroad of the Biodynamic Interface Between Cells and Their Microenvironment

  2025cites this paper
• Prevalence of targetable genomic alterations among a diverse population participating in the ASCO TAPUR Study

  2025cites this paper
• Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors

  2024cites this paper
• Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications

  2024cites this paper
• Functional characterization of PI3K C2 domain mutations detected in breast cancer circulating tumor cells and metastatic cells.

  2024cites this paper
• Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs

  2024cites this paper
• Computational investigations into structure and function impact of novel mutations identified in targeted exons from ovarian cancer cell lines

  2024cites this paper
• Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis

  2024cites this paper
• Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location

  2024cites this paper
• Prevalence and effect of PIK3CA H1047R somatic mutation among Indian head and neck cancer patients

  2024cites this paper
• Overcoming osimertinib resistance with AKT inhibition in EGFRm-driven Non-Small-Cell-Lung-Cancer with PIK3CA/PTEN alterations.

  2024cites this paper
• Targeting the RAS upstream and downstream signaling pathway for Cancer treatment.

  2024cites this paper
• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• Cryo-EM structures reveal two allosteric inhibition modes of PI3KαH1047R involving a re-shaping of the activation loop.

  2024cites this paper
• A convex formulation of covariate-adjusted Gaussian graphical models via natural parametrization

  2024cites this paper
• Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein

  2024cites this paper
• Predictive and prognostic biomarkers in gastrointestinal tract tumours.

  2024cites this paper
• Statistical Inference on High Dimensional Gaussian Graphical Regression Models

  2024cites this paper
• Genomic Alterations of Tumors in HER2-Low Breast Cancers

  2024cites this paper
• Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers

  2024cites this paper
• Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

  2024cites this paper
• Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression

  2024cites this paper
• Zirconium Hydride Catalysis Initiated by Tetrabutylammonium Fluoride.

  2024cites this paper
• PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia

  2023cites this paper
• Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA‐mutant cervical carcinoma via the PI3K/AKT pathway

  2023cites this paper
• Comparison of different noble metal-based screen-printed sensors for detection of PIK3CA point-mutations as biomarker for circulating tumor DNA

  2023cites this paper
• Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma

  2023influential citation
• Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective

  2023cites this paper
• A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation

  2023cites this paper
• Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy.

  2023cites this paper
• Recombinase polymerase amplification in combination with electrochemical readout for sensitive and specific detection of PIK3CA point mutations.

  2023cites this paper
• Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review

  2023influential citation
• Case report: PIK3CA somatic mutation leading to Klippel Trenaunay Syndrome and multiple tumors

  2023cites this paper
• Molecular basis and therapeutic targets in prostate cancer: A comprehensive review

  2023cites this paper
• Landscape of Genetic Mutations in Appendiceal Cancers

  2023influential citation
• Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes

  2023cites this paper
• Somatic gain-of-function mutations in BUD13 promote oncogenesis by disrupting Fbw7 function

  2023cites this paper
• Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer

  2023cites this paper
• Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis

  2023cites this paper
• A case of high‐risk neuroblastoma in a child with CLOVES syndrome

  2023cites this paper
• Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations

  2023cites this paper
• Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations

  2023cites this paper
• Altered expression of anti-apoptotic protein Api5 affects breast tumorigenesis

  2023cites this paper
• New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.

  2023cites this paper
• PHEVIR: an artificial intelligence algorithm that predicts the molecular role of pathogens in complex human diseases

  2022cites this paper
• Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy

  2022cites this paper
• A New View of Activating Mutations in Cancer

  2022cites this paper
• Detection of breast cancer-related point-mutations using screen-printed and gold-plated electrochemical sensor arrays suitable for point-of-care applications

  2022cites this paper
• PI3K/mTOR inhibitor omipalisib prolongs cardiac repolarization along with a mild proarrhythmic outcome in the AV block dog model

  2022cites this paper
• Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth

  2022cites this paper
• The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions.

  2022cites this paper
• Targeting the PI3K Pathway in Gynecologic Malignancies

  2022cites this paper
• Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma

  2022cites this paper
• S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions

  2022cites this paper
• PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression

  2022cites this paper
• Clinicopathological Significance of PTEN Expression and Its Prognostic Effect in Colorectal Adenocarcinoma Patients

  2022cites this paper
• Diagnostic and therapeutic biomarkers in colorectal cancer: a review.

  2022cites this paper
• Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration

  2022cites this paper
• The Importance of RTK Signaling Genes and their Inhibitors in Breast Cancer

  2022cites this paper
• In vitro analysis on inhibitory effect of sodium arsenite combined with astragaloside IV on HepG2 liver cancer cells

  2021cites this paper
• Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviours in the PI3K/mTOR Signalling Network

  2021cites this paper
• Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients

  2021cites this paper
• Chip-Based Digital Pcr Improves the Detection of Low-Rate pik3ca Mutations in Breast Cancer Patients

  2021cites this paper
• Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant

  2021cites this paper
• Epstein-Barr Virus-Associated Gastric Cancer: Old Entity with New Relevance

  2021cites this paper
• The structure-based cancer-related single amino acid variation prediction

  2021cites this paper
• Natural Polyphyllins (I, II, D, VI, VII) Reverses Cancer Through Apoptosis, Autophagy, Mitophagy, Inflammation, and Necroptosis

  2021cites this paper
• Genetic Analysis of Oligo-Metastatic Breast Cancer: Correlation with Clinicopathological Features

  2021cites this paper
• Reconciling the Biological and Transcriptional Variability of Hepatoblastoma with Its Mutational Uniformity

  2021cites this paper
• Printable graphene BioFETs for DNA quantification in Lab-on-PCB microsystems

  2021cites this paper
• Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer

  2021cites this paper